Ignite Creation Date:
2025-12-24 @ 11:33 PM
Ignite Modification Date:
2026-06-03 @ 3:58 PM
Study NCT ID:
NCT02407756
Status:
COMPLETED
Last Update Posted:
2020-11-27
First Post:
2015-03-31
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Determine the Safety and Tolerability of Dupilumab (REGN668/SAR231893) in Patients Aged ≥6 to <18 Years With Atopic Dermatitis (Eczema)
Sponsor:
Regeneron Pharmaceuticals
Organization: